LncRNA NEAT1 in the pathogenesis of liver-related diseases

  • Raed Obaid Saleh
  • , Adnan Taan Alkhafaji
  • , Jaafaru Sani Mohammed
  • , Pooja Bansal
  • , Harpreet Kaur
  • , Irfan Ahmad
  • , Ahmed Hjazi
  • , Israa Hussein Mohammed
  • , Mohammed Abed Jawad
  • , Ahmed Hussein Zwamel

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Abstract

Nuclear paraspeckle assembly transcript 1 (NEAT1) is a long noncoding RNA (lncRNA) that is widely expressed in a variety of mammalian cell types. Altered expression levels of the lncRNA NEAT1 have been reported in liver-related disorders including cancer, fatty liver disease, liver fibrosis, viral hepatitis, and hepatic ischemia. lncRNA NEAT1 mostly acts as a competing endogenous RNA (ceRNA) to sponge various miRNAs (miRs) to regulate different functions. In regard to hepatic cancers, the elevated expression of NEAT1 has been reported to have a relation with the proliferation, migration, angiogenesis, apoptosis, as well as epithelial-mesenchymal transition (EMT) of cancer cells. Furthermore, NEAT1 upregulation has contributed to the pathogenesis of other liver diseases such as fibrosis. In this review, we summarize and discuss the molecular mechanisms by which NEAT1 contributes to liver-related disorders including acute liver failure, nonalcoholic fatty liver disease (NAFLD), liver fibrosis, and liver carcinoma, providing novel insights and introducing NEAT1 as a potential therapeutic target in these diseases.

Original languageEnglish
Article numbere4006
JournalCell Biochemistry and Function
Volume42
Issue number3
DOIs
StatePublished - Apr 2024

Keywords

  • Apoptosis
  • Cancer
  • Liver disease
  • LncRNA NEAT1
  • miRs

Fingerprint

Dive into the research topics of 'LncRNA NEAT1 in the pathogenesis of liver-related diseases'. Together they form a unique fingerprint.

Cite this